These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27430377)

  • 1. Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells.
    Li J; Luo M; Wang Y; Shang B; Dong L
    Oncol Rep; 2016 Sep; 36(3):1345-52. PubMed ID: 27430377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells.
    Li S; Gu Z; Xiao Z; Zhou T; Li J; Sun K
    Int J Clin Exp Pathol; 2015; 8(2):1737-42. PubMed ID: 25973062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
    Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
    Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
    Lin X; Luo K; Lv Z; Huang J
    Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
    Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
    Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition.
    Rosendahl AH; Gundewar C; Said K; Karnevi E; Andersson R
    Pancreatology; 2012; 12(3):219-26. PubMed ID: 22687377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
    Qorri B; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
    Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M
    J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
    Matsuda Y; Yoshimura H; Suzuki T; Uchida E; Naito Z; Ishiwata T
    Cancer Sci; 2014 Sep; 105(9):1212-9. PubMed ID: 24975163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib suppresses fibroblast proliferation and collagen expression by inhibiting ERK1/2 and SMAD2/3 phosphorylation.
    Li F; Fan C; Zeng B; Zhang C; Chai Y; Liu S; Ouyang Y
    Mol Med Rep; 2012 Mar; 5(3):827-31. PubMed ID: 22200683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
    Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
    Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
    Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
    Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities.
    Zuo C; Hong Y; Qiu X; Yang D; Liu N; Sheng X; Zhou K; Tang B; Xiong S; Ma M; Liu Z
    Pancreatology; 2018 Apr; 18(3):328-333. PubMed ID: 29525378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
    Zhang J; He DH; Zajac-Kaye M; Hochwald SN
    Cell Cycle; 2014; 13(19):3143-9. PubMed ID: 25486573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.